Tesofensine Capsules

Description

Tesofensine Capsules 500mcg Australia

This product is intended for research purposes only. To be used by trained professionals only.

Tesofensine is a reuptake inhibitor that works on serotonin, noradrenaline, and dopamine. It was first discovered for its effectiveness in treating Parkinson’s disease and Alzheimer’s disease.

Regrettably, its research for these indicators was restricted because the research volunteers started to lose weight rapidly. Since then, tesofensine’s appetite-suppressing abilities have been studied for their use in treating obesity. This compound was shown in scientific studies to be more efficient than other weight reduction medicines, and it works by stimulating the cholinergic system in a roundabout way.

Tesofensine capsules, also known as TE, can boost the activity of three monoaminergic neurotransmitters in the brain. These neurotransmitters called serotonin, norepinephrine, and dopamine, regulate energy balance. Obesity and depression are also linked to these neurotransmitters. The results of a phase 2b clinical research that lasted for six months showed that participants saw a weight loss of approximately 25 pounds on average.

In addition, the research on Tesofensine capsules has demonstrated that it significantly affects the feelings of hunger but only has a modest effect on the amount of energy it expends. Both of these actions can potentially contribute to the powerful weight loss effect.

For more detailed information on Tesofensine, please visit our main category page, which offers insights into research, benefits, and potential side effects.

SERVING SIZE: 1 CAP

SERVINGS PER CONTAINER: 60

AMOUNT PER SERVING SIZE:  500mcg

References:

[1] A.Astrup, D.H.Meier, B.O.Mikkelsen, et al (2008) Weight loss produced by tesofensine in patients with Parkinson’s or Alzheimer’s disease – Obesity (a research journal) Silver Spring Md, vol. 16, no. 6, pp. 1363–1369, Jun. 2008.
[2] AB.Saniona (2018) Saniona’s tesofensine meets primary and secondary endpoints in Phase 3 obesity registration trial – Press Releases from GlobeNewswire News Room, Dec. 17, 2018.

Research use only. Not for human or animal consumption!

ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Australia Direct Peptides website: https://australia.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.

BUY Tesofensine Capsules ONLINE today From Australia Direct Peptides